RenovoRx Competitors and Similar CompaniesClear all

RenovoRx's competitors and similar companies include SynCore Biotechnology, NovoCure, TriSalus Life Sciences, Bausch Health and AngioDynamics.
RenovoRx
RenovoRx
RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors.
SynCore Biotechnology
SynCore Biotechnology
SynCoreBio (杏國新藥股份有限公司) is a biopharmaceutical company engaged in the research and development of drugs with a focus on oncology, ophthalmology, dermatology, and infectious diseases.
NovoCure
NovoCure
NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
TriSalus Life Sciences
TriSalus Life Sciences
TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors.
Bausch Health
Bausch Health
Bausch Health is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products.
AngioDynamics
AngioDynamics
AngioDynamics is a provider of medical devices.
Founding Date
Founding Date
2012
Founding Date
2008
Founding Date
2000
Founding Date
2009
Founding Date
1959
Founding Date
1988
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Los Altos, US HQ
Locations
TW HQ
Locations
Saint Helier, JE HQ
München, DE
Haifa, IL
Tokyo, JP
Root, CH
Malvern, US
New York, US
see more
Locations
Westminster, US HQ
Bannockburn, US
Cranston, US
Locations
Laval, CA HQ
Buenos Aires, AR
Wien, AT
Sarajevo, BA
Indaiatuba, BR
Porto Alegre, BR
Sao Paulo, BR
see more
Locations
Latham, US HQ
Oakville, CA
Hong Kong, HK
Rehovot, IL
Amsterdam, NL
Glens Falls, US
Marlborough, US
see more
Employees
Employees
7
Employees
40
Employees
1,488
Employees
106
Employees
20,700
Employees
8157% increase
Valuation ($)
Valuation ($)
24.8 m
Valuation ($)
N/A
Valuation ($)
1.8 b
Valuation ($)
117.2 m
Valuation ($)
3 b
Valuation ($)
282 m

Financial

Revenue (est.)
Revenue (est.)
$1.1m (FY, 2025)
Revenue (est.)
NT$23.3m (FY, 2024)
Revenue (est.)
$655.4m (FY, 2025)
Revenue (est.)
$45.2m (FY, 2025)
Revenue (est.)
$10.3b (FY, 2025)
Revenue (est.)
$292.5m (FY, 2025)
Cost of goods
Cost of goods
$327k (FY, 2025)
Cost of goods
NT$10.5m (FY, 2024)
Cost of goods
$166.9m (FY, 2025)
Cost of goods
$7m (FY, 2025)
Cost of goods
$1.7b (FY, 2025)
Cost of goods
$134.8m (FY, 2025)
Gross profit
Gross profit
$796k (FY, 2025)
Gross profit
NT$12.9m (FY, 2024)
Gross profit
$488.5m (FY, 2025)
Gross profit
$38.2m (FY, 2025)
Gross profit
$8.5b (FY, 2025)
Gross profit
$157.7m (FY, 2025)
Net income
Net income
($11.2m) (FY, 2025)
Net income
(NT$54.3m) (FY, 2024)
Net income
($136.2m) (FY, 2025)
Net income
($39.2m) (FY, 2025)
Net income
$120m (FY, 2025)
Net income
($34m) (FY, 2025)

Operating

Manufacturing Facilities
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
37 (FY, 2019)
Manufacturing Facilities
2 (FY, 2023)
Research and Development Centers
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
23 (FY, 2019)
Research and Development Centers
2 (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 10.2m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 52.2m
Total funding raised
N/A
Total funding raised
$ 352.1k
For sources of this data, please see the company profile

View Company Profiles

SynCore Biotechnology
HQ
TW
Employees
40

SynCoreBio (杏國新藥股份有限公司) is a biopharmaceutical company engaged in the research and development of drugs with a focus on oncology, ophthalmology, dermatology, and infectious diseases.

View company
NovoCure
HQ
Saint Helier, JE
Employees
1,488

NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.

View company
TriSalus Life Sciences
HQ
Westminster, US
Employees
106

TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors.

View company
Bausch Health
HQ
Laval, CA
Employees
20,700

Bausch Health is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products.

View company